RxSight Inc. (RXST)
NASDAQ: RXST
· Real-Time Price · USD
8.89
0.42 (4.96%)
At close: Sep 05, 2025, 3:59 PM
8.90
0.11%
After-hours: Sep 05, 2025, 06:29 PM EDT
RxSight Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L D D Revenue | 5.13M | 9.39M | 10.67M | 10.13M | 10.19M | 8.71M | 7.93M | 7.72M | 6.47M | 5.69M | 5.68M | 4.57M | 5.31M | 3.66M | 2.96M |
| L D D Revenue Growth | -45.32% | -12.02% | +5.38% | -0.60% | +16.93% | +9.86% | +2.75% | +19.23% | +13.84% | +0.09% | +24.38% | -13.97% | +45.07% | +23.47% | n/a |
| Service Warranty Service Contracts And Accessories Revenue | 1.5M | 1.32M | 1.02M | 955K | 870K | 882K | 765K | 679K | 619K | 401K | 328K | 268K | 216K | 181K | 140K |
| Service Warranty Service Contracts And Accessories Revenue Growth | +13.50% | +29.44% | +6.70% | +9.77% | -1.36% | +15.29% | +12.67% | +9.69% | +54.36% | +22.26% | +22.39% | +24.07% | +19.34% | +29.29% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 28.98M | 28.64M | 28.21M | 25.61M | 24.29M | 23.32M | 21.16M | 19.14M | 18.24M | 16.25M | 15.73M | 14.93M | 14.39M | 13.62M | 11.62M | 9.08M | 6.5M | 5.61M | 4.4M | 3.83M | 3.25M | 3.7M |
| Selling, General, and Administrative Revenue Growth | +1.19% | +1.51% | +10.16% | +5.42% | +4.15% | +10.20% | +10.57% | +4.95% | +12.21% | +3.33% | +5.39% | +3.74% | +5.64% | +17.22% | +28.02% | +39.59% | +15.88% | +27.44% | +15.11% | +17.73% | -12.14% | n/a |
| Research and Development Revenue | 10.22M | 10.37M | 9.21M | 8.84M | 8.29M | 8.03M | 7.34M | 7.1M | 7.4M | 7.21M | 6.68M | 6.39M | 6.19M | 6.72M | 5.92M | 5.38M | 6.56M | 6.64M | 5.27M | 5.8M | 5.08M | 5.78M |
| Research and Development Revenue Growth | -1.45% | +12.60% | +4.18% | +6.60% | +3.24% | +9.40% | +3.38% | -4.05% | +2.68% | +7.89% | +4.59% | +3.17% | -7.84% | +13.57% | +10.02% | -18.07% | -1.20% | +26.01% | -9.12% | +14.10% | -12.00% | n/a |